Personalized Computerized Inhibitory Control Training for OCD

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02378896

Enrollment

Registered

2015-03-04

Start date

2015-02-28

Completion date

2018-01-31

Last updated

2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive-Compulsive Disorder

Keywords

Cognitive Behavioral Therapy

Brief summary

This study will evaluate the effects of a computerized training program coupled with cognitive behavioral therapy (CBT) for OCD.

Detailed description

This study will evaluate the effectiveness of a computerized training program (called Personalized Computerized Inhibitory Training, or PCIT) coupled with cognitive behavioral therapies (CBT) consisting of Exposures and Response Prevention in treating obsessive compulsive disorder (OCD) in patients who previously underwent CBT, but still have residual symptoms.

Interventions

BEHAVIORALPersonalized Computer Program

Training with a personalized computerized inhibitory training program

BEHAVIORALCognitive Behavioral Therapy

Cognitive Behavioral Therapy (CBT), consisting of Exposure and Ritual Prevention Therapy

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Principal diagnosis of OCD (assessed by SCID). * Clinically significant OCD symptoms (Y-BOCS score of at least 16). * Have a history of completing a trial of at least 1 EX/RP sessions. * Have access to a computer or laptop.

Exclusion criteria

* Individuals with the following disorders will excluded: bipolar, psychosis, current major depressive disorder (assessed by SCID). * Patients with head injury and loss of consciousness of more than five minutes or a neurological condition affecting the central nervous system. * Patients taking a psychiatric medication will be asked to maintain a stable dose for 6 weeks prior to study entry. * Vision or hearing loss (although individuals with vision corrected by glasses or contacts will not be excluded). * Active suicidality warranting immediate clinical care.

Design outcomes

Primary

Measure	Time frame	Description
Obsessive-compulsive symptoms measured after 3 weeks of treatment	3 weeks	measured by Yale Brown Obsessive Compulsive Scale (YBOCS)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026